| SHFS | 8-K | bearish | 6/10 | SHF Holdings reported Q2 2026 revenue of $1.93M, up 4.8% YoY, driven by a 50.7% increase in loan program income to $0.8M | Aug 10, 2026 |
| LTCH | 8-K | bearish | 6/10 | Latch, Inc. (LTCH) reported Q2 2026 results with total revenue of $15.6M, down 18.1% YoY, driven by lower hardware and s | Aug 10, 2026 |
| CECO | 8-K | bullish | 8/10 | CECO reported a mixed Q2 2026 with GAAP net loss of $(34.8)M due to acquisition costs from the closed Thermon deal, but | Aug 10, 2026 |
| MITT | 8-K | bearish | 5/10 | MITT reported Q2 2026 EAD of $0.24 per share, a 10.9% miss versus consensus of $0.27, with the dividend fully covered at | Aug 10, 2026 |
| TH | 8-K | bullish | 7/10 | Target Hospitality reported Q2 2026 revenue of $85.5M (up 39% YoY) and a net loss of $0.09 per share, beating consensus | Aug 10, 2026 |
| VFF | 8-K | bullish | 6/10 | Village Farms reported Q2 2026 results with consolidated net sales of $63.977M, up 7% YoY, and GAAP diluted EPS from con | Aug 10, 2026 |
| AXSM | 8-K | neutral | 6/10 | Axsome Therapeutics reported Q2 2026 total net product revenue of $218.4M (+46% YoY), driven by AUVELITY ($180.3M, +51% | Aug 10, 2026 |
| CEVA | 8-K | bullish | 6/10 | Ceva reported Q2 2026 total revenue of $29.0 million, up 13% YoY, with licensing and related revenue of $18.2 million (u | Aug 10, 2026 |
| OPAL | 8-K | bearish | 7/10 | OPAL Fuels reported a net loss of $0.05 per share for Q2 2026, a 126% miss versus consensus estimates of $0.19 EPS, desp | Aug 10, 2026 |
| AAON | 8-K | bullish | 7/10 | AAON reported Q2 2026 results with record net sales of $627.0M (up 101.2% YoY) and diluted EPS of $0.68 (up 257.9% YoY), | Aug 10, 2026 |
| JBIO | 8-K | bullish | 7/10 | Jade Biosciences reported Q2 2026 results with net loss of -$0.76 per share (vs -$0.86 YoY), a pre-revenue clinical-stag | Aug 10, 2026 |
| SIF | 8-K | mixed | 5/10 | SIFCO Industries reported mixed Q3 fiscal 2026 results: revenue rose 18.3% YoY to $26.1M, but GAAP net income swung to a | Aug 10, 2026 |
| MLTX | 8-K | bullish | 7/10 | MoonLake announced positive topline Phase 3 IZAR-1 results for sonelokimab in psoriatic arthritis, meeting all clinical | Aug 10, 2026 |
| TNXP | 8-K | bullish | 6/10 | Tonix Pharmaceuticals reported Q2 2026 net product revenue of $13.5M, up 578% YoY from $2.0M, driven by $11.0M in TONMYA | Aug 10, 2026 |
| APGE | 8-K | bullish | 8/10 | Apogee reported Q2 2026 financial results amid a transformational period: positive Phase 2 APEX Part B data for lead ass | Aug 10, 2026 |
| SLN | 8-K | neutral | 5/10 | Silence Therapeutics reported Q2 2026 net loss of $12.3M ($0.09 per share), narrower than the $27.4M loss in Q2 2025 and | Aug 10, 2026 |
| CHMI | 8-K, 425 | bullish | 7/10 | Cherry Hill Mortgage Investment Corporation (CHMI) entered into a definitive merger agreement with TPG Mortgage Investme | Aug 10, 2026 |
| MITT | 8-K | bullish | 7/10 | TPG Mortgage Investment Trust (MITT) entered into a definitive merger agreement to acquire Cherry Hill Mortgage Investme | Aug 10, 2026 |
| RHP | S-3ASR, 8-K | bullish | 7/10 | Ryman Hospitality Properties (RHP) filed an automatic shelf registration (S-3ASR) on August 10, 2026, to register an ind | Aug 10, 2026 |
| CCXI | 8-K | neutral | 3/10 | Churchill Capital Corp XI (CCXI), a SPAC, has entered into a promissory note with its sponsor for up to $1.5 million for | Aug 10, 2026 |
| ORKA | 8-K | neutral | 5/10 | The company highlighted key upcoming catalysts including Week 28 data from EVERLAST-A and Week 16 data from EVERLAST-B, | Aug 10, 2026 |
| NESR | 8-K | bullish | 7/10 | NESR reported a massive Q2 2026 beat, with revenue of $520.8M (+59% YoY) and adjusted EPS of $0.44 (+169% YoY), both wel | Aug 10, 2026 |
| AIRS | 8-K | bearish | 7/10 | AirSculpt Technologies reported Q2 2026 revenue of $42.9M (-3% YoY), missing consensus of $44.1M, and GAAP EPS of -$0.02 | Aug 10, 2026 |
| JBGS | 8-K | bearish | 7/10 | JBG SMITH reported Q2 2026 Core FFO of $0.18 per share, down from $0.19 a year ago, with Same Store NOI declining 4.0% Y | Aug 10, 2026 |
| FERG | 8-K | mixed | 6/10 | Ferguson (FERG) reported FQ2 2026 (ended June 30) results with net sales of $8.75B, +4.6% YoY, and diluted GAAP EPS of $ | Aug 10, 2026 |
| NABL | 8-K | bearish | 7/10 | N-able reported Q2 2026 revenue of $138.2M (+5.9% YoY) and GAAP EPS of $0.01, and significantly lowered its full-year 20 | Aug 10, 2026 |
| ACH | 8-K | bearish | 6/10 | Accendra Health reported Q2 2026 revenue of $613.2M (down 10.1% YoY from $681.9M) and a GAAP loss from continuing ops of | Aug 10, 2026 |
| KEEL | 8-K | mixed | 5/10 | Keel Infrastructure reported Q2 2026 revenue of $30M, down 50% YoY, and a $0.11 GAAP loss per share, swinging from a $0. | Aug 10, 2026 |
| CTRN | 8-K | bullish | 6/10 | Citi Trends pre-announced strong preliminary Q2 2026 sales of $211.6M (+10.9% YoY), with comparable store sales growth o | Aug 10, 2026 |
| ASST | 8-K | bearish | 5/10 | Strive, Inc. reported Q2 2026 financial results showing a GAAP net loss of $257.6M, primarily driven by $234M in unreali | Aug 10, 2026 |